Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced that 1,000 patients ...
Endologix LLC announced it has reached a milestone of 1,000 patients who have been treated with percutaneous transmural ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback